Genesis Healthcare has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating. According to analysts' consensus price target of $0.57, Genesis Healthcare has a forecasted upside of ∞ from its current price of $0.00.What are analysts'price targets for Genesis HealthCare's stock?
1 brokerages have issued 1-year price objectives for Genesis Healthcare's shares. Their forecasts range from $0.57 to $0.57. On average, they expect Genesis Healthcare's stock price to reach $0.57 in the next year. View analysts' price targets for Genesis Healthcare or view top-rated stocks among Wall Street analysts.What is the ticker symbol for gengenesis healthcare?
Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."How many insiders own Genesis HealthCare (GME) stock?
35.20% of the stock of Genesis Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health. Only 12.61% of the stock of Genesis Healthcare is held by institutions.